Daxor Corporation announced the expansion of blood volume analysis (BVA) in three new hospitals through new analyzer purchases, and the utilization of Daxor?s ezBVA Lab service. These new acquisitions further fuel BVA sales growth and underscore its clinical relevance. New client and services wins include: BVA analyzer purchase at a 735-bed non-profit, tertiary, research and academic medical center located in northern New Jersey.

Daxor?s ezBVA Lab service extended to a regional academic medical center, Level I adult trauma center in Ohio. Daxor?s ezBVA Lab service extended to an academic, integrated health system located in South Carolina.